US 12,318,626 B2
Far red and near infrared light-mediated conditioning of tissues and/or blood to prevent reperfusion injury in endovascular therapies
Nicole Lohr, New Berlin, WI (US); and Michael Salinger, Milwaukee, WI (US)
Assigned to The Medical College of Wisconsin, Inc., Milwaukee, WI (US)
Filed by The Medical College of Wisconsin, Inc., Milwaukee, WI (US)
Filed on May 15, 2024, as Appl. No. 18/665,513.
Application 18/665,513 is a continuation of application No. 17/701,099, filed on Mar. 22, 2022, granted, now 11,998,757.
Claims priority of provisional application 63/164,751, filed on Mar. 23, 2021.
Prior Publication US 2024/0299766 A1, Sep. 12, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 18/24 (2006.01); A61N 5/06 (2006.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01); A61B 90/00 (2016.01)
CPC A61N 5/0601 (2013.01) [A61B 18/24 (2013.01); A61N 5/0613 (2013.01); A61B 2017/0019 (2013.01); A61B 2018/00351 (2013.01); A61B 2018/00577 (2013.01); A61B 2090/049 (2016.02); A61N 2005/0602 (2013.01); A61N 2005/063 (2013.01); A61N 2005/0651 (2013.01); A61N 2005/0663 (2013.01)] 15 Claims
OG exemplary drawing
 
1. A method for conditioning tissues in a subject to reduce reperfusion injury, the method comprising:
illuminating a region in a subject containing tissues with light from a light source having at least one wavelength selected from a range of 510 nanometers (nm) to 670 nm, wherein the tissues in the region are conditioned by the light emitted from the light source such that reperfusion injury of the tissues resulting from an endovascular therapy is significantly reduced.